LABCORP HOLDINGS INC. (LH) — financial distillation
Annual history (10-K)
Quarterly history (10-Q)
Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.
In brief, from the full filed history
- Revenue grew from $4.07B (period ending 2007-12-31) to $13.95B (period ending 2025-12-31) — a 7.1% annual pace across 18 year(s) of filed history.
- Net margin compressed from 11.7% to 6.3% over that same span.
- Across 53 tracked quarters, the strongest was $4.16B (quarter ending 2021-03-31) and the weakest was $1.14B (quarter ending 2008-09-30).
Annual — most recent 10-K
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $13.95B | 2025-12-31 | 10-K | 0000920148-26-000111 |
| Gross profit | $4.01B | 2025-12-31 | 10-K | 0000920148-26-000111 |
| Operating income | $1.38B | 2025-12-31 | 10-K | 0000920148-26-000111 |
| Net income | $876.5M | 2025-12-31 | 10-K | 0000920148-26-000111 |
| Diluted EPS | $10.46 | 2025-12-31 | 10-K | 0000920148-26-000111 |
| Total assets | $18.39B | 2025-12-31 | 10-K | 0000920148-26-000111 |
| Total liabilities | $9.76B | 2025-12-31 | 10-K | 0000920148-26-000111 |
| Cash & equivalents | $532.3M | 2025-12-31 | 10-K | 0000920148-26-000111 |
| Operating cash flow | $1.64B | 2025-12-31 | 10-K | 0000920148-26-000111 |
Quarterly — most recent 10-Q
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $3.73B | 2026-06-30 | 10-Q | 0000920148-26-000175 |
| Gross profit | $1.11B | 2026-06-30 | 10-Q | 0000920148-26-000175 |
| Operating income | $451.6M | 2026-06-30 | 10-Q | 0000920148-26-000175 |
| Net income | $298.7M | 2026-06-30 | 10-Q | 0000920148-26-000175 |
| Diluted EPS | $3.64 | 2026-06-30 | 10-Q | 0000920148-26-000175 |
| Total assets | $18.53B | 2026-06-30 | 10-Q | 0000920148-26-000175 |
| Total liabilities | $9.91B | 2026-06-30 | 10-Q | 0000920148-26-000175 |
| Cash & equivalents | $141.8M | 2026-06-30 | 10-Q | 0000920148-26-000175 |
| Operating cash flow | $191.5M | 2026-03-31 | 10-Q | 0000920148-26-000139 |
Reading
The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.
LabCorp Holdings Inc. (LH) operates in the clinical laboratory services sector, with a substantial scale evident from its annual revenue of $13.95 billion as of 2025-12-31. The company’s multi-year trajectory reveals steady growth, averaging a 7.1% annual pace over the past 18 years, as per the pre-computed trend facts. However, despite revenue expansion, net margins have contracted from 11.7% to 6.3% during this period.
The company’s financial performance indicates a focus on revenue generation, with quarterly revenues peaking at $4.16 billion in Q1 2021 and bottoming out at $1.14 billion in Q3 2008. This historical pattern underscores the volatility inherent in its business model. In terms of liquidity, LabCorp maintained $532.3 million in cash and equivalents as of 2025-12-31, though this figure has fluctuated over time.
In upcoming filings, investors should monitor the company’s ability to sustain revenue growth while addressing the shrinking net margins. Additionally, the management’s strategies to enhance operational efficiency and control costs will be crucial in determining future profitability and shareholder value.
Source: SEC EDGAR company facts for CIK 0000920148 · filings index